Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus by MARFELLA R et al.
 DOI: 10.1111/j.1464-5491.2006.01886.x
 
© 2006 The Authors.
 
974
 
Journal compilation © 2006 Diabetes UK. 
 
Diabetic Medicine
 
, 
 
23
 
, 974–981
 
Abstract
 
Background
 
Oxidative stress and increased inflammation have been reported
to be increased in subjects with diabetes and to be involved in the pathogenesis
of cardiovascular complications after myocardial infarction (MI). It is well
recognized that red wine has antioxidant and anti-inflammatory activities. We
examined the effects of moderate red wine intake on echocardiographic para-
meters of functional cardiac outcome in addition to inflammatory cytokines and
nitrotyrosine (oxidative stress marker), in subjects with diabetes after a first
uncomplicated MI.
 
Methods
 
One hundred and fifteen subjects with diabetes who had sustained a
first non-fatal MI were randomized to receive a moderate daily amount of red
wine (intervention group) or not (control group). Echocardiographic para-
meters of ventricular dys-synchrony, circulating levels of nitrotyrosine, tumour
necrosis factor-
 
α
 
 (TNF-
 
α
 
), interleukin-6 (IL-6), interleukin-18 (IL-18) and
C-reactive protein (CRP) were investigated at baseline and 12 months after
randomization.
 
Results
 
After 1 year of diet intervention, concentrations of nitrotyrosine
(
 
P <
 
 0.01), CRP (
 
P <
 
 0.01), TNF-
 
α
 
 (
 
P <
 
 0.01), IL-6 (
 
P <
 
 0.01) and IL-18
(
 
P <
 
 0.01) were increased in the control group compared with the intervention
group. In addition, myocardial performance index (
 
P <
 
 0.02) was higher, and
transmitral Doppler flow (
 
P <
 
 0.05), pulmonary venous flow analysis (
 
P <
 
 0.02)
and ejection fraction (
 
P <
 
 0.05) were lower in the control group, indicating
ventricular dys-synchrony. The concentrations of nitrotyrosine, CRP, TNF-
 
α
 
 and
IL-6 were related to echocardiographic parameters of ventricular dys-synchrony.
 
Conclusions
 
In subjects with diabetes, red wine consumption, taken with
meals, significantly reduces oxidative stress and pro-inflammatory cytokines as
well as improving cardiac function after MI. Moderate red wine intake with
meals may have a beneficial effect in the prevention of cardiovascular complica-
tions after MI in subjects with diabetes.
Diabet. Med. 23, 974–981 (2006)
 
Keywords
 
inflammation, myocardial infarction, oxidative stress, red wine
 
Abbreviations
 
 CRP, C-reactive protein; E/A ratio, early/late diastolic flow
ratio; EF, ejection fraction; HOMA, homeostasis model assessment; IL-6,
interleukin-6; IL-18, interleukin-18; IRT, Isovolumetric relaxation time; MI,
myocardial infarction; MPI, myocardial performance index; NO, nitric oxide;
TNF-
 
α
 
, tumour necrosis factor-
 
α
 
Blackwell Publishing LtdOxford, UKDMEi betic Medic ne0742-3071 , 200623riginal ArticlearticleRed w ne in iabetics with previous myocardial infarction R. Marfella et al.
Effect of moderate red wine intake on cardiac prognosis 
after recent acute myocardial infarction of subjects with 
Type 2 diabetes mellitus
 
R. Marfella*†, F. Cacciapuoti*, M. Siniscalchi‡, F. C. Sasso*, F. Marchese§, F. Cinone*, 
E. Musacchio‡, M. A. Marfella§, L. Ruggiero*, G. Chiorazzo*, D. Liberti*, G. Chiorazzo*, 
G. F. Nicoletti¶, C. Saron*, F. D’Andrea¶, C. Ammendola*, M. Verza* and L. Coppola*
 
*Department of Geriatrics and Metabolic Diseases, 
†Cardiovascular Research Center, Second 
University of Naples, Naples, ‡Department of 
Cardiology UTIC, Hospital Cardarelli, Campobasso, 
§Department of Medical Urgency, Hospital V. 
Rummo, Benevento and ¶Department of Surgery, 
Second University of Naples, Naples, Italy 
 
Accepted 29 November 2005
 
Correspondence to
 
: Raffaele Marfella, Via Emilio Scaglione, 141 I-80145 Naples, Italy. E-mail: raffaele.marfella@unina2.it
 Original article
 
975
 
© 2006 Authors. 
Journal compilation © 2006 Diabetes UK. 
 
Diabetic Medicine
 
, 
 
23
 
, 974–981
 
Introduction
 
Subjects with diabetes who sustain a non-fatal myocardial inf-
arction (MI) have a more complicated course, including more
frequent post-infarction angina, infarction extension, and con-
gestive heart failure [1]. A growing body of evidence suggests
that MI is associated with increased local and systemic inflam-
mation in subjects with diabetes: increased inflammatory as
well as oxidative processes seem likely mechanisms linking
diabetes to poor cardiac outcome after MI [2,3].
Moderate red wine intake has been associated with a signif-
icant reduction in risk for MI, generally in non-diabetic popu-
lations [4]. Moderate intake of any type of alcoholic beverage
appears to be beneficial, but some studies suggest that red wine
confers additional health benefits [5]. Regular drinking of red
wine has been suggested as the explanation for the ‘French par-
adox’, the relatively low incidence of coronary atherosclerosis
in France as compared with other Western countries, despite
the generally high intake of saturated fat in the French diet [6].
The chemical composition of red wine may contribute to its
apparent benefit. A series of studies suggest that the polyphe-
nolic compounds in red wine, such as flavonoids and resvera-
trol, may play an active role in limiting the initiation and
progression of atherosclerosis [7,8]. Polyphenolic compounds
appear to favourably maintain healthy blood vessels by reduc-
ing free-radical production as well as by promoting the forma-
tion of nitric oxide (NO), the key chemical relaxing factor that
plays a pivotal role in the regulation of vascular tone and in the
inhibition of adhesion of inflammatory cells to the vessel wall
[9]. Whether or not red wine consumption has a similar associ-
ation with CHD in individuals with diabetes after MI, how-
ever, has not been examined. A recent report noted an inverse
association between alcohol consumption, including red wine,
and CHD mortality in diabetic individuals [10]. The observa-
tions that several risk factors associated with poor outcome in
subjects with diabetes during acute coronary syndrome,
including inflammation [11], oxidative stress [12] and reduced
NO availability [9], may be favourably affected by red wine
likewise suggests the potential for particular cardiovascular
benefits of moderate red wine use in this high-risk group. We
therefore assessed whether moderate red wine intake is associ-
ated with a reduced risk for cardiovascular complications in
subjects with diabetes who have had a non-fatal MI. Specifi-
cally, we examined the effects of moderate red wine intake,
with meals, on echocardiographic parameters of functional
cardiac outcome as well as inflammatory cytokines and nitro-
tyrosine, in subjects with diabetes after a first uncomplicated
MI.
 
Methods
 
Study population
 
The study is a randomized secondary prevention trial to test
whether moderate alcohol consumption with meals may reduce
risk factors of cardiovascular disease complications after a first
and recent (< 2 months) MI in subjects with diabetes. Eligi-
ble patients were survivors of a first acute MI as diagnosed by
a cardiologist at any of the four recruiting hospitals in the
catchment area (Napoli, Benevento and Campobasso) between
2001 and 2004. All patients were assessed by cardiologists ac-
cording to the World Health Organization criteria for MI,
which require typical symptoms plus either elevations in car-
diac enzyme levels or diagnostic changes in the electrocardio-
gram [13]. Patients with the following conditions were not
enrolled: cardiac surgery or angioplasty during the past
6 months; non-ischaemic cardiomyopathy; implanted pace-
maker; or permanent tachyarrhythmias; non-cardiac diseases
such as inflammatory disorders, malignancy, or infection; pa-
tients who drank no alcohol. Eligible patients were < 70 years
old, were clinically stable, and had no medical or social condi-
tions that would limit their ability to participate in a dietary
trial. The study protocol was approved by the institutional
ethics committee for human subjects. Written informed con-
sent was obtained from all patients.
 
Randomization
 
After clinical stabilization, the patients were randomized in an
unblinded one-to-one fashion to receive either dietary advice
according to the Mediterranean diet, with red wine intake
of one 118-ml (4-oz) glass of wine each day [alcohol: 11.0 g:
(intervention group)], or no red wine or other alcohol con-
sumption (control group). Treatment was started within
36 
 
±
 
 12 days of MI. Patients were seen at 1, 3, 6, 9 and 12-
months. At baseline and 12 months after enrolment, patients
underwent follow-up, including echocardiography.
 
Dietary advice
 
In the intervention group, the mean recommended daily caloric
intake was 8372 kJ (2000 kcal). The recommended composi-
tion of the dietary regimen was: carbohydrates 178 g, proteins
73 g, saturated fat 9 g, monounsaturated fat 17 g, polyunsatu-
rated fat 8 g, sodium 1.1 g, potassium 3 g, calcium 0.5 g, phos-
phorus 1.2 g, fibre 25 g. This regimen was very similar to the
Mediterranean-style Step I diet. All patients were encouraged
to take physical activity (at least 1-h walk three times a week).
The control group followed similar dietary advice without red
wine or alcohol intake, thus the only difference between the
intervention and control groups was the red wine intake. All
patients were examined every third month. At the first session, a
thorough interview lasting for at least 1 h was performed. Every
patient was asked to describe their intake of foods and beverag-
es for the past 24 h, and dietary advice was adjusted individual-
ly and repeated every third month. The patients were asked at
every visit to prepare a written 4-day diary of foods and bever-
ages consumed. They were asked not to weigh the foods but to
describe in ordinary words the size of the single ingredients (e.g.
a small, medium, or large apple) or size of portions of food; in
addition, they were asked to describe in detail fat percentages,
especially in dairy produce and minced meat. Also, the patients
were asked to note their hot meals. The food diaries were re-
turned to the study nurse, who reviewed the contents; in case of
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doubt, the diary was returned to the patient with appropriate
clarifying questions. Analysis of the polyphenol profiles of
the red wine (Castel San Lorenzo DOC, Barbera, 2000) was
carried out by SEA Laboratories, Rome, Italy. The amount of
polyphenols was 1792 mg/l.
 
Echocardiography
 
All patients underwent two-dimensional and Doppler echocar-
diography before starting the intervention. Myocardial syn-
chronization was assessed by diastolic filling time, mitral
regurgitation time [the ratio of velocity time intervals of mitral
early (E) and late (A) diastolic flows, E/A ratio], pulmonary
vein flow analysis (PVFs/PVFd ratio), the effective ejection
time (EF), right ventricular relaxation time (RV-RT
 
m
 
) and my-
ocardial performance index (MPI). Doppler velocities and time
intervals were measured from mitral inflow and left ventricular
outflow recordings. Isovolumetric relaxation time (IRT) was
the time interval from cessation of left ventricular outflow to
onset of mitral inflow, ejection time (ET) was the time interval
from the onset and cessation of left ventricular outflow, and
mitral early diastolic (E) flow deceleration time (EDT) was the
time interval between the peak E velocity and the end of the
early diastolic flow. Isovolumetric contracting time (ICT) was
calculated by subtracting ET and IRT from the total systolic
time interval. The ratio of velocity time intervals (vti) of mitral
early (E) and late (A) diastolic flows (Evti/Avti) was calculated.
MPI was calculated by using the formula MPI = (IRT + ICT)/
ET. The function of right ventricle (RV-RT
 
m
 
) was evaluated by
Doppler tissue imaging (DTI) of the right ventricular tricuspid
anulus.
 
Plasma analyses
 
Routine analyses samples were drawn after fasting at randomi-
zation and every third month. Serum concentrations of tumour
necrosis factor-
 
α
 
 (TNF-
 
α
 
), interleukin-6 (IL-6) and interleukin-
18 (IL-18), as well as nitrotyrosine levels, were determined
in duplicate using a highly sensitive, quantitative sandwich
enzyme assay (Santa Cruz Biotechnology, Santa Cruz, CA, USA;
R & D Systems, Minneapolis, MN, USA). High-sensitivity C-
reactive protein (CRP) was assayed by immunonephelometry
on a Behring Nephelometer 2 (Dade Behring, Marburg, Ger-
many). In our laboratory, the median (interquartile range) for
these values in a group of 50 healthy participants of both sexes
(
 
n
 
 = 25 for each) were as follows: IL-6, 2.0 pg/ml (0.3–5.2 pg/
ml); TNF-
 
α
 
, 1.7 pg/ml (0.5–4.2 pg/ml); and IL-18, 119 pg/ml
(50–175 pg/ml). Nitrotyrosine was determined because this
modified amino acid is a product of free-radical (O
 
2–
 
) inter-
action with NO. The interaction of O
 
2–
 
 with NO is very rapid
and leads to inactivation of NO and production of the potent
oxidant peroxynitrite. Detection of nitrotyrosine is strongly
suggestive of increased generation of peroxynitrite [14]. Assays
for serum total and high-density lipoprotein cholesterol, trig-
lyceride, and glucose levels were performed in the hospital’s
chemistry laboratory. Plasma insulin levels were assayed by
radioimmunoassay (Ares, Serono, Italy). Insulin sensitivity in the
fasting state was assessed with homeostasis model assessment
(HOMA) and calculated with the following formula: fasting
plasma glucose (mmol/l) 
 
×
 
 fasting serum insulin (
 
µ
 
U/ml) divided
by 25.
 
Statistical analysis
 
Data are presented as group mean 
 
±
 
 
 
SD
 
. One-way 
 
ANOVA
 
 was
used to compare baseline data, followed by Scheffé’s test for
pairwise comparisons. We compared data using a Wilcoxon
test for IL-6, TNF-
 
α
 
, IL-18, HOMA score and triglycerides.
Multiple comparisons were made with 
 
ANOVA
 
 followed by post-
hoc analysis (Student–Newmann–Keuls test) to locate the sig-
nificant difference indicated with 
 
ANOVA
 
. Linear regression and
correlation were used to assess relationships between varia-
bles. A value of 
 
P
 
 < 0.05 was considered significant. All calcu-
lations were made on an IBM PC computer (SPSS Inc., Chicago,
IL, USA; version 12.01).
 
Results
 
Patients characteristics
 
A total of 131 patients were enrolled in the study, 93 patients
(71%) during hospitalization for MI. Sixty-eight patients were
randomized to the Mediterranean diet with red wine (interven-
tion group), and 63 to the Mediterranean diet without red
wine or other alcohol consumption. Five patients were
excluded from the study, three because of withdrawal of con-
sent and two because of lack of compliance. Three patients had
ultrasound scanning images that could not be analysed. A
further eight patients died during the study period. Thus, 115
patients completed the study. The demographic and clinical
baseline data are given in Table 1. There was no difference in
age, smoking status, and fasting glucose, insulin, HbA
 
1c
 
, cho-
lesterol or triglyceride levels. The troponin I levels during myo-
cardial infarction were also similar. The use of anti-ischaemic
agents, angiotensin-converting enzyme inhibitors and the
angiotensin 2 receptor (AT2) antagonist did not differ between
groups at randomization or during follow-up. There was no
difference in the use of 
 
β
 
-blockers and long-acting nitrates,
calcium-antagonists, vitamins, and angiotensin-converting
enzyme inhibitors at 12 months of follow-up. Both groups
were > 80% compliant with statin treatment. All patients were
treated with insulin. At randomization, there was no difference
in the alcohol intake between groups.
 
Dietary intervention
 
After 12 months, the intake of fruit and vegetables was similar in
both groups. However, we found a similar intake of fatty fish,
red meat, and contents of polyunsaturated fatty acids between the
groups. Main dietary kJ recorded after 12 months follow-up was
not significantly different between the groups [control group
8163 kJ (1950 kcal); intervention group 8581 kJ (2050 kcal)].
There was no difference in weight loss between the groups,
all patients lost at least 2% of their initial body weight with a
mean decrease of 2.8 
 
±
 
 1.5 kg (Table 2). In the control group,
 Original article
 
977
 
© 2006 Authors. 
Journal compilation © 2006 Diabetes UK. 
 
Diabetic Medicine
 
, 
 
23
 
, 974–981
 
analysis of the food diaries did not show any evidence of
alcohol intake.
 
Echocardiographic parameters
 
Echocardiographic/Doppler measurements are presented in
Table 1. At baseline, there was no difference in infarct segment
length (
 
P =
 
 0.10), wall motion scores (
 
P =
 
 0.11), ejection
fraction (
 
P =
 
 0.15), MPI (
 
P =
 
 0.12), transmitral Doppler
flow (
 
P =
 
 0.16) and pulmonary venous flow analysis (
 
P =
 
0.12), between the groups. After dietary intervention, MPI
was higher (
 
P <
 
 0.02), and transmitral Doppler flow (
 
P <
 
0.05) and pulmonary venous flow lower (
 
P <
 
 0.02) in the
control group compared with the intervention group (Fig. 1;
Table 2).
 
Laboratory analysis
 
At baseline, there was no difference in fasting glucose and in-
sulin concentrations. HOMA scores, serum lipid and blood
pressure levels were similar in the two groups (Table 1). Serum
TNF-
 
α
 
, IL-6, IL-18, nitrotyrosine and CRP levels were similar
in the two groups (Table 1). After 12 months, a significant
decrease in blood glucose levels, total cholesterol and low-
density lipoprotein cholesterol levels, as well in blood pressure
and heart rate, was seen in both groups (
 
P <
 
 0.001 for the reduction
in both groups) (Table 2). In the 115 patients who completed
the study, a significant increase in high-density lipoprotein
cholesterol level was observed only in the intervention group
(
 
P <
 
 0.02), whereas triglyceride levels remained unchanged in
both groups (Table 2). In the intervention group, liver function
tests did not change (data not shown). Compared with the
intervention group, the control group had lower insulin con-
centrations and HOMA scores. In the control group, serum
TNF-
 
α
 
 (
 
P <
 
 0.01), IL-6 (
 
P <
 
 0.01), IL-18 (
 
P <
 
 0.01), CRP
(
 
P <
 
 0.01) and nitrotyrosine levels (
 
P <
 
 0.01) were higher than
in the intervention group ( Fig. 2, Table 2).
After the intervention period, the decline in serum TNF-
 
α
 
,
IL-6, CRP and nitrotyrosine levels correlated with the changes
in EF, RV-RT
 
m
 
, E/A ratio, PVFs/PVFd ratio and MPI
 
 
Intervention (n = 57) Control (n = 58)
Age (years) 36.5 ± 4.6 35.1 ± 5.1
Body mass index (kg/m2) 28.6 ± 2.1 27.6 ± 1.5
Waist–hip ratio 0.72 ± 0.07 0.73 ± 0.04
Systolic blood pressure (mmHg)  125 ± 5.9  123 ± 5.1
Diastolic blood pressure (mmHg)  84 ± 3.8  83 ± 3.5
Fasting glucose (mmol/l) 7.5 ± 0.5 7.7 ± 0.4
Fasting insulin (µU/ml) 12.5 ± 3.2 12.1 ± 2.3
HbA1c (%) 7.2 ± 1.3 7.3 ± 1.5
HOMA 3.3 ± 0.4 3.2 ± 0.2
Total cholesterol (mmol/l) 6.7 ± 0.4 6.8 ± 0.6
High-density lipoprotein cholesterol (mmol/l) 1.22 ± 0.3 1.24 ± 0.3
Triglyceride (mmol/l) 2.52 ± 0.6 2.56 ± 0.3
TNF-α (pg/ml) 5.8 ± 1.5 5.5 ± 0.7
IL-6 (pg/ml) 4.2 ± 0.9 4.4 ± 0.5
IL-18 (pg/ml)  227 ± 27.4  229 ± 25.8
C-reactive protein (mg/l) 3.4 ± 0.7 3.3 ± 0.3
Nitrotyrosine (µM) 0.55 ± 0.06 0.53 ± 0.04
LVM/BSA (g/m2) 84.1 ± 11 82.2 ± 10
LVM/h2 (g/m2) 60.4 ± 8 58.3 ± 8
Fractional shortening (%)  36 ± 3  37 ± 6
LVIDD (mm) 42.7 ± 5.1 41.1 ± 4.9
Infarct segment length (%)  35 ± 2.2  36 ± 3.2
Interventriculum septum (mm) 10.9 ± 1.6 9.8 ± 1.1
Left ventricular posterior wall (mm) 10.1 ± 1.3 9.5 ± 1.8
Mitral deceleration (ms)  156 ± 13  155 ± 19
E/A ratio 0.9 ± 0.2 0.9 ± 0.3
Myocardial performance index 0.57 ± 0.08 0.58 ± 0.04
PVFs/PVFd ratio 1.41 ± 0.08 1.42 ± 0.5
RV-RTm (ms) 42.4 ± 5 10.3 ± 4
Ejection fraction (%)  51 ± 7  52 ± 11
LVM/BSA, left ventricular mass index/body surface area; LVM/h2, left ventricular mass 
index/height2; LVIDD, left ventricular internal diastolic diameter; E/A ratio, the ratio of 
velocity time intervals of mitral early (E) and late (A) diastolic flows; PVF, pulmonary vein 
flow; RV-RTm, right ventricular relaxation time.
Data are presented as group mean (SD). There were no statistically significant differences between 
intervention and control groups at baseline.
Table 1 Clinical characteristics of the study 
patients
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(Table 3). To assess the independent association of changes
in echocardiographic parameters of cardiac function with
changes in serum nitrotyrosine, IL-6, TNF-α and CRP levels,
a multivariate analysis was performed, in which MPI was the
dependent variables and IL-6, TNF-α and CRP levels were
the independent variables. The model explained 75% of the
variability in the change of MPI, nitrotyrosine, IL-6, TNF-α
and CRP concentrations.
 
 
Intervention group Control group P
Body mass index (kg/m2) −2.8 ± 1.1 −2.7 ± 1.5 NS
Waist–hip ratio −0.04 ± 0.01 −0.03 ± 0.01 NS
Systolic blood pressure (mmHg) −2.1 ± 0.5 −2.2 ± 0.4 NS
Diastolic blood pressure (mmHg) −1.5 ± 0.2 −1.6 ± 0.3 NS
Fasting glucose (mmol/l) −1.2 ± 0.4 −1.3 ± 0.3 NS
Fasting insulin (µU/ml) −3.8 ± 1.5 −2.0 ± 1.1 < 0.05
HbA1c (%) −1.1 ± 0.6 −1.2 ± 0.7 NS
HOMA −1.2 ± 0.9 −0.9 ± 0.3 < 0.05
Total cholesterol (mmol/l) −1.8 ± 0.4 −1.7 ± 0.5 NS
High-density lipoprotein cholesterol (mmol/l) 1.8 ± 0.7 0.9 ± 0.2 < 0.05
Triglyceride (mmol/l) −0.9 ± 0.1 −0.8 ± 0.1 NS
IL-18 (pg/ml) −61.7 ± 5.1 −28.2 ± 3.8 < 0.05
LVM/BSA (g/m2) −15 ± 2.3 −6 ± 1.2 < 0.05
LVM/h2 (g/m2)  −13 ± 3.1 −5 ± 1.1 < 0.05
Fractional shortening (%)  5 ± 1.0 6 ± 1.6 NS
Interventricular serptum (mm) 0.1 ± 0.07 0.3 ± 0.09 NS
LVPW (mm) 0.1 ± 0.06 0.2 ± 0.01 NS
PVFs/PVFd ratio 0.19 ± 0.02 0.7 ± 0.01 < 0.05
RV-RTm (ms)  −21 ± 4 −9 ± 5 < 0.05
LVM/BSA, left ventricular mass index/body surface area; LVM/h2, left ventricular mass index/
height2; PVF, pulmonary vein flow; RV-RTm, right ventricular relaxation time.
Data are presented as group mean (SD). There were no statistically significant differences between 
intervention and control groups at baseline.
Table 2 Parameters changes after dietary 
intervention in study population
Figure 1 Echocardiographic parameters in study population (, intervention group; , control group). *P < 0.05.
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Discussion
To the best of our knowledge, there have been no studies inves-
tigating the effects of moderate red wine intake on oxidative
stress, inflammatory markers, and functional cardiac outcome
in patients with a recent MI. The main findings of our study
demonstrate that moderate consumption of red wine with
meals was associated with a significant reductions in oxidative
stress and inflammatory reaction and improvement of cardiac
function in middle-aged diabetic survivors of a recent MI. In
our study, heart function, assessed by echocardiographic
parameters of cardiac synchronization, improved significantly
in the intervention group. In particular, moderate red wine
intake resulted in significant improvement of dys-synchrony
between right and left ventricular contraction and relaxation.
The lower MPI values, which measure both systolic and
diastolic parameters of ventricular function [15], indicate
better functional outcome after MI in patients randomized to
receive red wine. Moreover, the increased diastolic filling time,
the reduction of mitral regurgitation, and the increased effec-
tive ejection time in the intervention group suggest that red
wine intake may improve cardiac synchronization after MI.
Studies have identified dys-synchrony between right and left
ventricular contraction and relaxation as an independent
predictor of heart failure and cardiac mortality in patients
with heart failure and cardiac ischaemic diseases [16]. Thus,
Figure 2 Cytokine and nitrotyrosine levels in study population (, intervention group; , control group). *P < 0.05.
 
 
Nitrotyrosine TNF-α IL-6 IL-18 CRP
TNF-α* 0.20† – – – –
IL-6* 0.32‡ 0.08 – – –
IL-18* 0.21† 0.11 0.22† – –
C-reactive protein* 0.27† 0.10 0.10 0.12 –
HOMA 0.30‡ 0.19† 0.19† 0.24† 0.18†
Ejection fraction −0.21† −0.18† −0.31‡ −0.15 −0.24‡
E/A ratio −0.19† −0.32‡ −0.32‡ −0.10 −0.22‡
Myocardial performance index 0.27† 0.45§ 0.21† 0.12 0.39‡
PVFs/PVFd, ratio −0.22† −0.27‡ −0.31‡ −0.16 −0.20‡
RV-RTm 0.21† 0.19† 0.32‡ 0.08 0.19†
*Log-transformed; †P < 0.05; ‡P < 0.02; §P < 0.01.
PVF, pulmonary vein flow; RV-RTm, right ventricular relaxation time.
Data are presented as group mean (SD).
Table 3 Relationships between the changes of 
nitrotyrosine and pro-inflammatory cytokines 
with echocardiographic parameters in 
intervention group
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the improvement of cardiac function suggests that moderate
red wine intake may reduce cardiovascular complications after
MI in subjects with diabetes.
Diabetes mellitus is characterized by a high incidence of
cardiovascular complications after MI, such as heart failure
and extension of infarct size [1], and oxidative stress has been
recognized as a major pathophysiological link between cardio-
vascular complications and diabetes after MI [2,17]. However,
an increase of inflammatory cytokines may also contribute to
the development of cardiovascular complications after MI,
and a close relationship between oxidative stress and a pro-
inflammatory state has been demonstrated in both diabetic [2]
and non-diabetic patients [18]. Lower mortality as a result of
coronary heart disease is associated with moderate consump-
tion of red wine [6]. The cardiovascular benefits of moderate
wine consumption have been thought to stem, at least partly,
from antioxidant activities of red wine [19]. A recent report
suggested that red wine increases the antioxidant power of
plasma in humans [20]. Since that study, several authors have
published results confirming that the consumption of moder-
ate amounts of red wine elicits a prompt, although temporary,
rise of plasma antioxidative defences [21]. Consequently, it
has been suggested that this property may provide a clue to the
role of certain wines in the so-called ‘French paradox’ [6]. This
hypothesis has also been supported by a number of studies
suggesting that moderate consumption of red wine may be more
effective than consumption of other alcoholic beverages in
decreasing the risk of coronary heart disease mortality [22].
Other studies and reviews have failed to show a beneficial
effect for red wine, however, and hence it could be concluded
that other lifestyle factors such as diet, exercise, socio-
economic status, or pattern of alcohol consumption may have
played a role in reducing the rate of atherosclerosis in wine
drinkers.
However, support for a more pronounced cardioprotective
effect for red wine as compared with other alcoholic beverages
first emerged from the Copenhagen City Heart Study, in which
13 285 men and women were observed for 12 years [23]. The
results from this study suggested that patients who drank wine
had half the risk of dying from coronary heart disease or stroke
as those who never drank wine. Those who drank beer and
spirits did not experience this advantage. The additional ben-
efit of red wine is supported further by an analysis of 13 studies
involving 209 418 participants. This analysis showed a 32%
risk reduction of atherosclerotic disease with red wine intake,
which was greater than the 22% risk reduction for beer
consumption [5]. Red wine has been suggested to be cardio-
protective via various mechanisms such as its antioxidant
activity and effects to increase NO availability [9]. Our findings
support the hypothesis that the reduced O2– production and
increased NO availability by red wine intake may be an import-
ant mechanism for protection of the ischaemic heart in sub-
jects with diabetes. The observation that red wine intake was
associated with lower nitrotyrosine levels indicates reduced
generation of the potent oxidant peroxynitrite, produced by
the interaction of O2– with NO that leads to inactivation of
NO. The peroxynitrite anion is cytotoxic because it inhibits
mitochondrial electron transport, oxidizes sulfydryl groups in
protein, initiates lipid peroxidation without the requirement
for transition metals, and nitrates amino acids such as tyrosine,
which affects many signal transduction pathways such as the
inflammation pathway [24]. There is considerable evidence
demonstrating the anti-inflammatory properties of red wine,
including inhibition of reactive oxygen species in neutrophils,
monocytes and macrophages [25]. The release of various
cytokines from macrophages and lymphocytes has been
shown to be inhibited by red wine [26].
Because polyphenolic compounds exhibit antioxidant and
anti-inflammatory properties, we hypothesized that red wine
would prevent oxidant-dependent inflammatory responses in
myocardial ischaemia and improve heart function. Consistent
with this interpretation, we also found that synchrony bet-
ween right and left ventricular contraction and relaxation
positively correlated with changes in nitrotyrosine, a good
marker of peroxynitrite formation [14] and pro-inflammatory
cytokine levels in subjects with diabetes after MI randomized
to moderate red wine intake. As we excluded any associated
conditions by through clinical and laboratory investigations,
it is reasonable to hypothesize that in the clinical setting any
changes in cardiac function can be interpreted as a conse-
quence of red wine intake itself. In support of this, red wine
intake may reduce the inflammatory process, and thus im-
prove cardiac contractile function [27]. During the past
decade, TNF-α and IL-1β have been shown to be present in the
sera of septic patients and responsible for most, if not all, of the
reversible cardiac depression often seen with this syndrome
[28]. Interest in these findings has been amplified by reports of
elevated circulating as well as intracardiac TNF-α levels in
patients with heart failure [29]. Accordingly, we found that
patients randomized to diet without red wine intake had
higher circulating levels of TNF-α, IL-6, IL-18 and CRP and
impaired cardiac function as compared with patients rand-
omized to diet with red wine intake. Furthermore, it might be
speculated that the favourable effect of red wine intake on
cardiac function might also be because of its ability to decrease
circulating TNF-α, IL-6, IL-18 and CRP. Interestingly enough,
the concentrations of TNF-α, IL-6 and CRP were positively
related to myocardial performance index and right ventricular
relaxation time and negatively related to transmitral Doppler
flow, pulmonary venous flow analysis and ejection fraction.
All of these observations suggest that cytokines might be partly
responsible for dys-synchrony between right and left ventricu-
lar contraction and relaxation observed in subjects with dia-
betes randomized to diet without red wine intake after MI.
Recent research has begun to clarify some of the intracellular
signalling mechanisms that contribute to cardiac myocyte
contractile dysfunction. IL-6 has been shown to rapidly sup-
press voltage-dependent Ca2+ current (ICa-L) in adult rat ven-
tricular myocytes [30]. Consistent with these data, higher
concentrations of recombinant human TNF-α have been
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shown [31] to result in rapid and reversible declines in contrac-
tile function of isolated hamster papillary muscles or of adult
guinea pig and rabbit ventricular myocytes.
A direct effect of alcohol should not be excluded. It is now
well recognized that a moderate alcohol intake has a favoura-
ble effect on cardiovascular disease in subjects with diabetes
[10]. However, it should be stressed that red wine consump-
tion causes a decrease in oxidative stress [9] and inflammatory
cytokines [11] independently of the alcohol content of the
wine. It has been suggested that polyphenols contained in red
wine may account for these protective effects.
In conclusion, our study supports previous work showing
that MI is associated with increased oxidative stress and
inflammation in subjects with diabetes. In addition, we have
demonstrated that red wine ingestion reverses these changes.
Thus, moderate red wine intake may provide another safe
method for down-regulating oxidative stress and inflamma-
tion in subjects with diabetes, and thus reduce cardiovascular
complications after MI.
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